PL351127A1 - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents

Cyclocarbamate derivatives as progesterone receptor modulators

Info

Publication number
PL351127A1
PL351127A1 PL00351127A PL35112700A PL351127A1 PL 351127 A1 PL351127 A1 PL 351127A1 PL 00351127 A PL00351127 A PL 00351127A PL 35112700 A PL35112700 A PL 35112700A PL 351127 A1 PL351127 A1 PL 351127A1
Authority
PL
Poland
Prior art keywords
receptor modulators
progesterone receptor
cyclocarbamate
derivatives
cyclocarbamate derivatives
Prior art date
Application number
PL00351127A
Inventor
Puwen Zhang
Eugene A Terefenko
Horace Fletcher Iii
Andrew Fensome
Jay E Wrobel
Lin Zhi
Todd K Jones
Keith B Marschke
Christopher M Tegley
Original Assignee
American Home Prod
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by American Home Prod, Ligand Pharm Inc filed Critical American Home Prod
Publication of PL351127A1 publication Critical patent/PL351127A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL00351127A 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators PL351127A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
PL351127A1 true PL351127A1 (en) 2003-03-24

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00351127A PL351127A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Country Status (19)

Country Link
EP (1) EP1173426A1 (en)
JP (1) JP2002543193A (en)
KR (1) KR20010114250A (en)
CN (1) CN1145618C (en)
AU (1) AU766428B2 (en)
BG (1) BG106079A (en)
BR (1) BR0010213A (en)
CA (1) CA2371726A1 (en)
CZ (1) CZ20013951A3 (en)
EA (1) EA004512B1 (en)
HU (1) HUP0201609A3 (en)
IL (1) IL146280A0 (en)
MX (1) MXPA01011286A (en)
NO (1) NO321361B1 (en)
NZ (1) NZ515355A (en)
PL (1) PL351127A1 (en)
SG (1) SG114650A1 (en)
SK (1) SK15912001A3 (en)
TR (1) TR200103286T2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510278A (en) * 2004-04-27 2007-10-30 Wyeth Corp method for producing compounds, product, and, compound
WO2006077821A1 (en) * 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. Aromatic sulfone compound as aldosterone receptor modulator
US8314094B2 (en) 2007-10-05 2012-11-20 Msd K.K Benzoxazinone derivative
CN111925353B (en) * 2020-08-31 2022-04-08 苏州大学附属第二医院 Preparation method of 2-thiophenecarbonitrile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (en) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-DISUBSTITUTED 1,4-DIHYDRO-2H-3,1-BENZOXAZINE-2-ONE THAT ARE APPLICABLE AS HIV REVERSTRANSCRIPTASE INHIBITORS, INTERMEDIATE PRODUCTS AND METHODS FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
TR200103286T2 (en) 2002-07-22
EA200101176A1 (en) 2002-04-25
HUP0201609A3 (en) 2002-12-28
AU766428B2 (en) 2003-10-16
BG106079A (en) 2002-05-31
KR20010114250A (en) 2001-12-31
CN1349517A (en) 2002-05-15
EA004512B1 (en) 2004-04-29
JP2002543193A (en) 2002-12-17
NZ515355A (en) 2004-02-27
SK15912001A3 (en) 2002-06-04
NO20015378D0 (en) 2001-11-02
MXPA01011286A (en) 2003-07-14
CN1145618C (en) 2004-04-14
SG114650A1 (en) 2005-09-28
CA2371726A1 (en) 2000-11-09
CZ20013951A3 (en) 2002-05-15
HUP0201609A2 (en) 2002-08-28
EP1173426A1 (en) 2002-01-23
AU4688600A (en) 2000-11-17
BR0010213A (en) 2002-02-19
NO20015378L (en) 2002-01-03
IL146280A0 (en) 2002-07-25
NO321361B1 (en) 2006-05-02

Similar Documents

Publication Publication Date Title
EG25606A (en) Glucocorticoid receptor modulators
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
IL146223A0 (en) Steroid derivatives
EP1170020A4 (en) Patches for external use
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
IL148058A0 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives
MXPA01011294A (en) Tetracyclic progesterone receptor modulator compounds and methods.
AU3238102A (en) Estrogen receptor modulators
HUP0203332A3 (en) Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them
IL146151A0 (en) Human-g-protein receptor
IL130169A0 (en) Indole derivatives
ZA200405653B (en) Tetracyclic heterocompounds as estrogen receptor modulators
HUP0202479A3 (en) Indole derivatives
PL351127A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
GB9927215D0 (en) Hormone receptor expression
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
HK1043789A1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
HK1043989A1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
GB9913649D0 (en) Estrogen receptor
SI1235776T1 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HK1043988A1 (en) Indoline derivatives as progesterone antagonists
MXPA01011310A (en) Quinazolinone and benzoxazine derivatives as progesterone receptor modulators.
AU2002255847A1 (en) Aminopyridine derivatives as estrogen receptor modulators
SI1467998T1 (en) Tetracyclic heterocompounds as estrogen receptor modulators

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)